Otolaryngology Doctors in Bloomfield, CT Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Sheldon Nova, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4 Northwestern Dr, Suite 300, Bloomfield, CT 06002 Phone: 860-243-8997    Fax: 860-769-6803

Ronald J Saxon, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4 Northwestern Dr, Suite 300, Bloomfield, CT 06002 Phone: 860-243-8997    Fax: 860-769-6803

Dr. G Gordon Snyder Iii, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 701 Cottage Grove Rd, A-230, Bloomfield, CT 06002 Phone: 860-242-5274    Fax: 860-242-3643

Stephen George Wolfe, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4 Northwestern Dr, Suite 300, Bloomfield, CT 06002 Phone: 860-243-8997

News Archive

Rockefeller scientists uncover genetic mutation responsible for tuberculosis vulnerability

If you live in the United States, you are unlikely to come into contact with the microbe that causes tuberculosis. Your odds of encountering the microbe are so low, in fact, that risk factors for the disease can easily go unnoticed: If you happened to carry a gene that predisposed you to tuberculosis, you likely wouldn't know.

Vapers develop cancer-related gene deregulation as cigarette smokers

If you think vaping is benign, think again. A small USC study shows that e-cig users develop some of the same cancer-related molecular changes in oral tissue as cigarette smokers, adding to the growing concern that e-cigs aren't a harmless alternative to smoking.

Aging does not appear to be a factor in poor sleep

Aging does not appear to be a factor in poor sleep, a new survey of more than 150,000 Americans shows. In fact, subjective sleep quality seems to improve over a lifetime, with the fewest complaints coming from people in their 80s.

Some American ob/gyn residency programs fail to offer formal training in menopause medicine

A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.

CytRx' bafetinib receives EMEA COMP positive opinion for treatment of CML

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).

Read more Medical News

› Verified 4 days ago